Home > Insider Trading > Filing (0001209191-21-068922)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1601830	Recursion Pharmaceuticals Inc.	RXRX	Biological Products, (No Disgnostic Substances) (2836)	464099738

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1856369	Christopher Gibson	C/O Recursion Pharmaceuticals 41 S. Rio Grande Street Salt Lake City UT 84101	Chief Executive Officer	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Class B Common Stock	Disposition	2021-11-21	1,100,000	$0.00	8,217,883	No	5	G	Direct
Class B Common Stock	Acquisiton	2021-11-21	550,000	$0.00	550,000	No	5	G	Indirect	By LAHWRAN-3 LLC
Class B Common Stock	Acquisiton	2021-11-21	550,000	$0.00	550,000	No	5	G	Indirect	By LAHWRAN-4 LLC
Class B Common Stock	Disposition	2021-12-07	15,467	$20.43	8,202,416	No	4	S	Direct
Class B Common Stock	Disposition	2021-12-07	1,200	$21.06	8,201,216	No	4	S	Direct
Class B Common Stock	Disposition	2021-12-07	3,025	$20.49	146,975	No	4	S	Indirect	By Gibson Family Trust
Class B Common Stock	Disposition	2021-12-07	100	$21.07	146,875	No	4	S	Indirect	By Gibson Family Trust

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	5	G	Direct
No	5	G	Indirect	By LAHWRAN-3 LLC
No	5	G	Indirect	By LAHWRAN-4 LLC
No	4	S	Direct
No	4	S	Direct
No	4	S	Indirect	By Gibson Family Trust
No	4	S	Indirect	By Gibson Family Trust

Footnotes

Sales are pursuant to a 10b5-1 trading plan established by the Reporting Person.
The sales price reported herein is a weighted average price. These shares were sold in multiple lots at prices ranging from $20.01 to $20.99 per share. Full sale price information for each lot is available to the Issuer's stockholders and the staff of the U.S. Securities and Exchange Commission upon their written request.
The sales price reported herein is a weighted average price. These shares were sold in multiple lots at prices ranging from $21.02 to $21.11 per share. Full sale price information for each lot is available to the Issuer's stockholders and the staff of the U.S. Securities and Exchange Commission upon their written request.
The sales price reported herein is a weighted average price. These shares were sold in multiple lots at prices ranging from $20.07 to $21.06 per share. Full sale price information for each lot is available to the Issuer's stockholders and the staff of the U.S. Securities and Exchange Commission upon their written request.